$VCNX Preclinical Data on Vaccinex Inc. AntiSEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research httpsglobenewswire.comnewsrelease2018121216659080enPreclinicalDataonVaccinexIncAnti

$VCNX Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research https://globenewswire.com/news-release/2018/12/12/1665908/0/en/Preclinical-Data-on-Vaccinex-Inc-Anti

08:49 EST 12 Dec 2018 | Odi Bruckman

$VCNX Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research https://globenewswire.com/news-release/2018/12/12/1665908/0/en/Preclinical-Data-on-Vaccinex-Inc-Anti-SEMA4D-Monoclonal-Antibody-in-Combination-with-Checkpoint-Inhibitors-Published-in-Cancer-Immunology-Research.html …

More From BioPortfolio on "$VCNX Preclinical Data on Vaccinex, Inc. Anti-SEMA4D Monoclonal Antibody in Combination with Checkpoint Inhibitors Published in Cancer Immunology Research https://globenewswire.com/news-release/2018/12/12/1665908/0/en/Preclinical-Data-on-Vaccinex-Inc-Anti"